PATfix™ pDNA platform for monitoring pDNA purification process

Cell & Gene Therapy Insights 2021; 7(10), 1437

10.18609/cgti.2021.190

Published: 15 November 2021
FastFacts


Watch the video or read the poster to learn about:

  • The importance of pDNA as an enabling product in the production of mRNA, AAV, and other therapeutic vectors
  • How the PATfix™ pDNA platform using CIMac™ pDNA column offers fast and efficient solution for problems related to pDNA upstream and downstream processes
  • How the PATfix™ pDNA platform can be used to optimally adjust pDNA production and purification procedures of pDNA according to your needs, increasing pDNA yield and purity and reducing the cost of its production

Nejc Pavlin is a Project Manager in Process Analytics Development department at BIA Separations, a Sartorius Company. He has extensive experience in analytics development of different biological molecules such as pDNA, mRNA, Adeno-associated viruses, all widely used in modern therapeutics. He manages several projects for various biotech clients, mainly in the field of new generation gene therapy products. He holds a PhD in Chemistry from the University of Ljubljana, Slovenia.